— Know what they know.
Not Investment Advice
Also trades as: IHL.AX (ASX) · $vol 0M

IXHL NASDAQ

Incannex Healthcare Limited
1W: -3.3% 1M: -1.8% 3M: -19.6% YTD: -72.6% 1Y: -75.2% 3Y: -97.8%
$3.21
-0.04 (-1.23%)
 
Weekly Expected Move ±8.6%
$3 $3 $3 $3 $4
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $38.4M mcap · 10M float · 1.97% daily turnover · Short 28% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
34.9 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 14055.6%
Cost Advantage
35
Intangibles
37
Switching Cost
35
Network Effect
39
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. IXHL has No discernible competitive edge (34.9/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. ROIC of 14055.6% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
Oct 02, 2026
DCF
5
ROE
1
ROA
1
D/E
2
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. IXHL receives an overall rating of B-. Strongest factors: DCF (5/5), P/B (4/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5).
Rating Change History
DateFromTo
2026-10-01 C+ B-
2026-09-25 B- C+
2026-09-04 B B-
2026-05-22 B- B
2026-05-11 B B-
2026-05-06 B- B
2026-04-24 C+ B-
2026-04-01 B- C+
2026-03-02 C+ B-
2026-02-27 B- C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
0
Earnings Quality
42
Growth
52
Value
41
Momentum
50
Safety
0
Cash Flow
30

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-0.49
Distress Zone
Piotroski F-Score
5/9
✗ ✗ ✗ ✓ ✓ ✓ ✓ ✗ ✓
Beneish M-Score
—
—
Ohlson O-Score
-0.95
Bankruptcy prob: 27.9%
Moderate
Credit Rating
B+
Score: 32.7/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.29x
Accruals: -101.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. IXHL scores -0.49, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. IXHL scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. IXHL's implied 27.9% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. IXHL receives an estimated rating of B+ (score: 32.7/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-2.87x
PEG
-0.09x
P/S
0.00x
P/B
0.59x
P/FCF
-2.69x
P/OCF
—
EV/EBITDA
0.30x
EV/Revenue
-247.70x
EV/EBIT
0.30x
EV/FCF
1.24x
Earnings Yield
-139.04%
FCF Yield
-37.16%
Shareholder Yield
17.66%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. IXHL currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.824
NI / EBT
×
Interest Burden
1.095
EBT / EBIT
×
EBIT Margin
-829.826
EBIT / Rev
×
Asset Turnover
0.002
Rev / Assets
×
Equity Multiplier
1.146
Assets / Equity
=
ROE
-163.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. IXHL's ROE of -163.9% is driven by Asset Turnover (0.002), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1152 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$3.21
Median 1Y
$0.13
5th Pctile
$0.01
95th Pctile
$3.55
Ann. Volatility
189.7%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Joel Latham
Chief Executive Officer
$656,464 $— $1,127,739
Luigi M. Barbato,
M.D. Chief Medical Officer
$264,063 $233,104 $497,167
Joseph Swan Financial
ancial Officer
$150,650 $— $201,193

CEO Pay Ratio

1:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $1,127,739
Avg Employee Cost (SGA/emp): $1,484,750
Employees: 12

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
12
0.0% YoY
Revenue / Employee
—
Profit / Employee
$-1,608,500
NI: $-19,302,000
SGA / Employee
$1,484,750
Avg labor cost proxy
R&D / Employee
$434,167
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
ROE -13.5% -11.9% 1.9% 1.7% 1.4% 63.0% -3.7% -1.3% -1.6% -1.64%
ROA -12.7% -11.8% 1.7% 1.4% 1.2% 53.8% -2.8% -1.3% -1.4% -1.43%
ROIC 1.9% -17.1% 17.8% -5.3% -6.6% -13.6% 30.2% -8.2% 140.6% 140.56%
ROCE -9.3% -10.4% -59.9% -1.1% -2.4% -6.2% -4.9% -87.8% -99.8% -99.83%
Gross Margin 78.5% — — — 1.0% 1.0% -1.9% — — —
Operating Margin -9.0% — — — -812.0% -417.0% -282.0% — — —
Net Margin -12.3% — — — -538.4% -491.2% -534.0% — — —
EBITDA Margin 0.0% — — — -533.2% -466.4% -586.2% — — —
FCF Margin -9.5% -19.8% -30.0% -38.0% -630.9% -440.2% -141.6% -209.3% -200.1% -200.11%
OCF Margin -9.5% -19.6% -29.1% -36.9% -614.8% -375.0% -154.5% -222.4% -215.9% -215.93%
ROE 3Y Avg snapshot only 39.89%
ROA 3Y Avg snapshot only 16.50%
ROIC Economic snapshot only -50.42%
Cash ROA snapshot only -25.45%
NOPAT Margin snapshot only -395.52%
Pretax Margin snapshot only -908.77%
R&D / Revenue snapshot only 182.53%
SGA / Revenue snapshot only 319.21%
SBC / Revenue snapshot only 92.80%
Valuation
Metric Trend Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
P/E Ratio -42877.82 -680.31 86.98 69.06 58.58 54.94 -1.07 -2.04 -0.72 -2.866
P/S Ratio 529294.99 19155.92 12777.03 8180.84 83647.98 30010.99 643.71 1203.37 538.52 0.000
P/B Ratio 5772.54 81.05 165.71 117.08 133.97 1161.54 5.00 1.70 0.69 0.587
P/FCF -55666.48 -968.31 -426.24 -215.39 -132.58 -68.18 -4.55 -5.75 -2.69 -2.691
P/OCF — — — — — — — — — —
EV/EBITDA — -1182.54 -329.57 -121.36 -54.11 -34.70 -0.80 -0.88 0.30 0.301
EV/Revenue 529199.47 19052.27 12697.06 8128.69 83342.67 30064.51 501.54 542.21 -247.70 -247.698
EV/EBIT -61873.96 -772.47 -269.70 -107.53 -53.90 -34.37 -0.79 -0.87 0.30 0.298
EV/FCF -55656.43 -963.07 -423.57 -214.02 -132.09 -68.30 -3.54 -2.59 1.24 1.238
Earnings Yield -0.0% -0.1% 1.1% 1.4% 1.7% 1.8% -93.3% -49.0% -1.4% -1.39%
FCF Yield -0.0% -0.1% -0.2% -0.5% -0.8% -1.5% -22.0% -17.4% -37.2% -37.16%
Price/Tangible Book snapshot only 0.687
Shareholder Yield snapshot only 17.66%
Leverage & Solvency
Metric Trend Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Current Ratio 18.84 37.63 9.02 6.70 2.88 1.80 2.86 48.27 48.81 48.812
Quick Ratio 18.84 37.63 9.02 6.70 2.88 1.80 2.86 48.27 48.81 48.812
Debt/Equity 0.00 0.00 0.03 0.02 0.03 4.25 0.02 0.00 0.00 0.001
Net Debt/Equity -1.04 -0.44 -1.04 -0.75 -0.49 2.07 -1.10 -0.94 -1.00 -1.004
Debt/Assets 0.00 0.00 0.02 0.02 0.02 0.37 0.01 0.00 0.00 0.001
Debt/EBITDA — -0.04 -0.05 -0.03 -0.01 -0.13 -0.00 -0.00 -0.00 -0.001
Net Debt/EBITDA — 6.43 2.08 0.78 0.20 -0.06 0.23 1.07 0.95 0.954
Interest Coverage — — — — — -118.28 -160.97 -158.07 -174.82 -174.815
Equity Multiplier 1.06 1.01 1.14 1.18 1.52 11.51 1.53 1.02 1.08 1.083
Cash Ratio snapshot only 45.383
Debt Service Coverage snapshot only -173.625
Cash to Debt snapshot only 705.323
FCF to Debt snapshot only -179.266
Defensive Interval snapshot only 575.9 days
Efficiency & Turnover
Metric Trend Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Asset Turnover 0.01 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.002
Inventory Turnover — — — — — — — — — —
Receivables Turnover 1.23 — 1.41 0.05 0.00 0.01 0.04 0.02 0.02 0.017
Payables Turnover 0.06 0.08 0.03 0.03 0.00 0.00 0.05 0.12 0.74 0.740
DSO 296 0 258 7554 103966 33466 8456 19114 21253 21252.8 days
DIO 0 0 0 0 — — 0 0 0 0.0 days
DPO 5653 4575 11004 12289 — — 7321 2974 493 493.3 days
Cash Conversion Cycle -5357 -4575 -10746 -4734 — — 1135 16140 20760 20759.5 days
Fixed Asset Turnover snapshot only 0.851
Cash Velocity snapshot only 0.001
Capital Intensity snapshot only 848.593
Growth (YoY)
Metric Trend Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue — — — — -93.3% -86.2% -61.5% -61.5% 3.8% 3.79%
Net Income — — — — 8.7% 3.7% -2.6% -2.9% -3.5% -3.51%
EPS — — — — 140.4% 3.3% -3.4% -3.6% -4.5% -4.47%
FCF — — — — -3.4% -2.1% -81.8% -1.1% -51.8% -51.83%
EBITDA — — — — — -6.4% -5.3% -2.5% -1.6% -1.56%
Op. Income — — — — -14.5% -4.2% -2.9% -90.0% -14.3% -14.31%
OCF Growth snapshot only -68.12%
Asset Growth snapshot only 3.28%
Equity Growth snapshot only 5.01%
Debt Growth snapshot only -74.26%
Shares Change snapshot only -27.71%
Growth Quality
Metric Trend Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue Stability — — — — — — — — 0.50 0.498
Earnings Stability — — — — — — — — 0.44 0.441
Margin Stability — — — — — — — — 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.20 0.200
Earnings Smoothness — — — — — — — — — —
ROE Trend — — — — — — — — -2.03 -2.032
Gross Margin Trend — — — — — — — — -2.16 -2.160
FCF Margin Trend — — — — — — — — 120.11 120.114
Sustainable Growth Rate — — 1.9% 1.7% 1.4% 63.0% — — — —
Internal Growth Rate — — -2.5% -3.3% -6.3% 1.2% — — — —
Cash Flow Quality
Metric Trend Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
OCF/Net Income 0.77 0.70 -0.20 -0.31 -0.43 -0.69 0.26 0.38 0.29 0.288
FCF/OCF 1.00 1.01 1.03 1.03 1.03 1.17 0.92 0.94 0.93 0.927
FCF/Net Income snapshot only 0.267
CapEx/Revenue 0.0% 20.9% 96.1% 1.2% 17.6% 7.1% 7.7% 10.6% 20.9% 20.91%
CapEx/Depreciation snapshot only 0.037
Accruals Ratio -0.03 -0.04 2.00 1.88 1.70 0.91 -2.10 -0.78 -1.02 -1.018
Sloan Accruals snapshot only 1.339
Cash Flow Adequacy snapshot only -1032.790
Dividends & Buybacks
Metric Trend Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — 0.0% 0.0% 0.0% 0.0% — — — —
FCF Payout Ratio — — — — — — — — — —
Total Payout Ratio — — 0.0% 0.0% 0.0% 0.0% — — — —
Div. Increase Streak — — — — — — — — — —
Chowder Number — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 17.7% 17.66%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -1.8% 12.9% 12.91%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -1.8% 12.9% 12.91%
DuPont Factors
Metric Trend Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 0.87 0.87 0.82 0.824
Interest Burden (EBT/EBIT) 1.44 1.14 -3.12 -1.57 -0.93 -0.63 1.09 1.09 1.10 1.095
EBIT Margin -8.55 -24.66 -47.08 -75.60 -1546.27 -874.79 -632.06 -620.69 -829.83 -829.826
Asset Turnover 0.01 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.002
Equity Multiplier 1.06 1.01 1.14 1.18 1.20 1.17 1.29 1.06 1.15 1.146
Per Share
Metric Trend Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
EPS (Diluted TTM) $-0.01 $-0.49 $2.54 $2.02 $1.51 $1.16 $-6.04 $-5.26 $-5.23 $-5.23
Book Value/Share $0.08 $4.15 $1.33 $1.19 $0.66 $0.05 $1.29 $6.30 $5.47 $5.47
Tangible Book/Share $0.08 $1.82 $1.33 $1.19 $0.66 $0.05 $1.29 $6.30 $5.47 $5.47
Revenue/Share $0.00 $0.02 $0.02 $0.02 $0.00 $0.00 $0.01 $0.01 $0.01 $0.00
FCF/Share $-0.01 $-0.35 $-0.52 $-0.65 $-0.67 $-0.93 $-1.42 $-1.87 $-1.40 $-0.67
OCF/Share $-0.01 $-0.34 $-0.50 $-0.63 $-0.65 $-0.79 $-1.55 $-1.99 $-1.51 $-0.67
Cash/Share $0.08 $1.83 $1.42 $0.92 $0.34 $0.12 $1.45 $5.91 $5.50 $5.50
EBITDA/Share $0.00 $-0.28 $-0.67 $-1.14 $-1.62 $-1.84 $-6.32 $-5.51 $-5.75 $-5.75
Debt/Share $0.00 $0.01 $0.03 $0.03 $0.02 $0.23 $0.02 $0.01 $0.01 $0.01
Net Debt/Share $-0.08 $-1.82 $-1.38 $-0.89 $-0.32 $0.11 $-1.43 $-5.90 $-5.49 $-5.49
Per Employee
Metric Trend Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Employee Count snapshot only 12
Revenue/Employee snapshot only $7166.67
Income/Employee snapshot only $-5366259.00
EBITDA/Employee snapshot only $-5906583.33
FCF/Employee snapshot only $-1434129.08
Assets/Employee snapshot only $6081583.33
Market Cap/Employee snapshot only $3859411.58
Academic Models
Metric Trend Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Altman Z-Score — — — — — — — — — -0.489
Altman Z-Prime snapshot only 0.615
Piotroski F-Score 2 2 2 2 4 2 3 4 5 5
Beneish M-Score — — — — 624.56 — — — — —
Ohlson O-Score snapshot only -0.948
ROIC (Greenblatt) snapshot only -99.90%
Net-Net WC snapshot only $5.46
Credit
Metric Trend Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Credit Rating snapshot only B+
Credit Score 89.00 76.88 76.11 76.56 75.96 53.57 32.39 64.94 32.70 32.698
Credit Grade snapshot only 14
Credit Trend snapshot only -43.264
Implied Spread (bps) snapshot only 650.000
Industry Credit Rank snapshot only 25
Sector Credit Rank snapshot only 24

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms